Lubeluzole. Neuronal injury inhibitor, glutamate release inhibitor

Drugs of the Future

Volumn 22, Issue 6, 1997, Pages 629-633

  Graul, A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; LUBELUZOLE; NEUROPROTECTIVE AGENT;

BRAIN INJURY; BRAIN ISCHEMIA; DOG; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; SHORT SURVEY;

EID: 0030801561     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.06.410776     Document Type: Short Survey

References (35)

1. Stokbroekx, R.A., Grauweb, G.A. (Janssen Pharmaceut. NV). 4-[(2 - Benzothiazolyl)methylamino] - α - [(3,4 - difluorophenoxy)-methyl]-1-piperidineethanol. EP 501552, EP 573473, JP 94505012, US 5434168, WO 9214731.
2. Prous, J.R. Treatment of cerebrovascular diseases. In: The Year's Drug News - Therapeutic Targets, 1995 Edition, Prous Science Publishers, Barcelona, 1995, 115-34.
3. Lesage, A.S., De Loore, K.L., Osikowska-Evers, B., Peeters, L., Leysen, J.E. Lubeluzole, a novel neuroprotectant, inhibits the glutamate-activated NOS pathway. Soc Neurosci Abst 1994, 20(Part 1): Abst 82.6.
4. Lesage, A.S., De Loore, K.L., Osikowska-Evers, B., Peeters, L., Leysen, J.E. Lubeluzole, a novel neuroprotectant, inhibits the glutamate activated NOS pathway. 4th IBRO World Cong Neurosci (July 9-14, Kyoto) 1995, Abst B1.9.
5. Lesage, A.S., De Loore, K.L., Osikowska-Evers, B., Peeters, L., Leysen, J.E. Lubeluzole, a novel neuroprotectant, inhibits the glutamate-activated NOS pathway. J Cerebr Blood Flow Metab 1995, 15(Suppl. 1): Abst XLV-19.
6. Maiese, K., TenBroeke, M., Kue, I. Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J Neurochem 1997, 68: 710-4.
7. Lesage, A.S., Peeters, L., Leysen, J.E. Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway. J Pharmacol Exp Ther 1996, 279: 759-66.
8. Osikowska-Evers, R., Wilhelm, D., Nebel, U., Hennemann, P., Scheufler, E., Tegtmeier, F. The effects of the novel neuroprotective compound lubeluzole on sodium current and veratridine induced sodium load in rat brain neurons and synaptosomes. J Cerebr Blood Flow Metab 1995, 15(Suppl. 1): Abst XLIII-16.
9. 2+-overload induced by veratridine in the CA1 region of hippocampal slices. Pharmacol Res 1995, 31(Suppl.): 124.
10. +-channel function as an in vitro model of the ischemia penumbra: Action of lubeluzole and other neuroprotective drugs. Brain Res 1997, 745: 210-21.
11. Scheller, D., De Ryck, M., Lesage, A., Clincke, G., Tegtmeier, F. Lubeluzole reduces extracellular glutamate in the peri-infarct zone of a thrombotic infarct in rats. Soc Neurosci Abst 1995, 21 (Part 2): Abst 409.6.
12. De Ryck, M., Keersmaekers, R., Clincke, G., Janssen, M., Van Reel, S. Lubeluzole, a novel benzothiazole, protects neurologic function after cerebral thrombotic stroke in rats: An apparent stereospecific effect. Soc Neurosci Abst 1994, 20(Part 1): Abst 82.5.
13. De Ryck, M., Scheller, D., Clincke, G., Janssen, M., Van Reet, S. Lubeluzole, a novel benzothiazole, protects neurologic function, reduces infarct size, and blocks peri-infarct glutamate rise after cerebral thrombotic stroke in rats. Cerebrovasc Dis 1995, 5(4): Abst 229.
14. De Ryck, M., Keersmaekers, R., Duytschaever, H., Claes, C., Clincke, G., Janssen, M., Van Reet, G. Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats. J Pharmacol Exp Ther 1996, 279: 748-58.
15. Scheller, D., De Ryck, M., Clincke, M., Tegtmeier, F. Lubeluzole, a neuroprotectant aimed at acute stroke therapy, prevents the extracellular rise of glutamate in the peri-infarct zone. 1st Cong Ger Neurosci Soc (Feb 24-27, Berlin) 1996, 160.
16. Scheller, D., Kolb, J., Szathmary, S., Zacharias, E., De Ryck, M., v. Reempts, J., Clincke, G., Tegtmeier, F. Extracellular changes of glutamate in the periinfarct zone. Effect of lubeluzole. J Cerebr Blood Flow Metab 1995, 15(Suppl. 1): Abst XLIII-15.
17. De Ryck, M., De Prins, E., Nolten, C., Marrannes, R., Clincke, G. Lubeluzole improves ischemic penumbra measured by cortical spreading depressions in rats. Soc Neurosci Abst 1995, 21 (Part 2): Abst 411.7.
18. De Ryck, M. Protection of neurological function in stroke models and neuroprotective properties of lubeluzole. Cardiovasc Dis 1997, 7(Suppl.2): 18-30.
19. Aronowski, J., Strong, R., Grotta, J.C. Treatment of experimental focal ischemia in rats with lubeluzole. Neuropharmacology 1996, 35: 689-93.
20. Grotta, J.C. Treatment of focal ischaemia in rats with lubeluzole. Cerebrovasc Dis 1997, 7(Suppl. 2): 31-4.
21. Grotta, J., Aronowski, J., Strong, R. Combination reperfusion and neuroprotection therapy for stroke. Neurology 1996, 46(2, Suppl.): Abst P06.102.
22. Aronowski, J., Strong, R., Grotta, J.C. Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia. Stroke 1996, 27: 1571-7.
23. Sugiyama, A., Ni, C., Arita, J., Eto, K., Hashimoto, K. Effects of lubeluzole on repolarization phase in canine heart assessed by endocardial monophasic action potential (MAP) recording. Jpn J Pharmacol 1995, 67(Suppl. 1): Abst P1-167.
24. Sugiyama, A., Ni, C., Arita, J., Eto, K., Xue, Y.-X., Hashimoto, K. Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording. Toxicol Appl Pharmacol 1996, 139: 109-14.
25. Hacke, W., Hennerici, H., Hantson, L., Diener, H.C. Lubeluzole - A new neuroprotectant agent in the treatment of acute ischemic stroke: Results of a cardiovascular safety study in stroke patients Neurology 1996, 46(2, Suppl.): Abst P06.002.
26. Diener, H.C., Hacke, W., Lees, K., Timmerhuis, T., Haan, J., Hantson, L., Hennerici, M. Cardiovascular safety of lubeluzole in patients with acute ischemic stroke. Cerebrovasc Dis 1996, 6(Suppl. 2): Abst P392.
27. Diener, H.-C. Lubeluzole. IBC Conf Stroke. Curr Underst Potential Ther Agents Clin Trials (Sept 18-19, London) 1996.
28. Diener, H.C., Hacke, W., Hennerici, M., Radberg, J., Hantson, L., De Keyser, J. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Stroke 1996, 27: 76-81.
29. Hantson, L. Lubeluzole: A new experimental neuroprotective agent in the acute treatment of ischemic stroke. IBC 3rd Int Symp Recent Adv Underst Ther Ischemic Stroke (Nov 30-Dec 1, Philadelphia) 1994.
30. Radberg, J., Diener, H.C., Hacke, W., Hennerici, M., Eriksson, B. Lubeluzole in the acute treatment of ischaemic stroke. Acta Neurol Scand 1996, 94(Suppl. 167): 21.
31. Diener, H.-C., Hacke, W., Hennerici, M., De Keyser, J., Radberg, J., Hantson, L. The effects of lubeluzole in the acute treatment of ischemic stroke: Results of a phase-2 trial. Stroke 1995, 26(1): Abst 155.
32. Diener, H.C., Hacke, W., Hennerici, M., De Keyser, J., Radberg, J., Hantson, L. Lubeluzole in the acute treatment of ischemic stroke: Results of a phase-2 trial. J Cerebr Blood Flow Metab 1995, 15(Suppl. 1): Abst XXIV-4.
33. Hennerici, M., Diener, H.C., Hacke, W., De Keyser, J., Radberg, J., Hantson, L. Lubeluzole in the acute treatment of ischemic stroke: Results of a late phase II trial. Cerebrovasc Dis 1995, 5(4): Abst 61.
34. Gratta, J., Hantson, L., Wessel, T. The efficacy and safety of lubeluzole in patients with acute ischemic stroke. Stroke 1997, 28(1): Abst 205.
35. Diener, H.C., Kaste, M., Hacke, W., Koudstaal, P., Hennerici, M., Wessel, T., Hantson, L. Lubeluzole in acute ischemic stroke. Stroke 1997, 28(1): Abst 206.